**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Birth: January 1, 1980
* Date of Admission: March 10, 2023
* Date of Discharge: March 25, 2023
* Hospital Number: 1234567

**Chief Complaint:**

John Doe, a 43-year-old male, was admitted to the endocrinology unit on March 10, 2023, with a chief complaint of increased thirst and frequent urination over the past two weeks.

**Medical History:**

John has no significant medical history except for hypertension, which is well-controlled with medications. He has a family history of type 2 diabetes in his maternal aunt.

**Physical Examination:**

Upon admission, John's physical examination revealed a BMI of 35 kg/mÂ², blood pressure of 140/90 mmHg, and a pulse rate of 72 beats per minute. His funduscopic examination was normal, and his foot examination showed no signs of peripheral neuropathy or ulcers.

**Laboratory Results:**

Laboratory tests revealed the following:

* Fasting plasma glucose (FPG): 200 mg/dL
* Glycosylated hemoglobin (HbA1C): 7.5%
* Random glucose value: 250 mg/dL
* Lipid profile: Total cholesterol 200 mg/dL, HDL 40 mg/dL, LDL 120 mg/dL, triglycerides 150 mg/dL
* Serum creatinine: 1.2 mg/dL
* Albuminuria: Negative

**Diagnosis:**

Based on the laboratory results and physical examination, John was diagnosed with type 2 diabetes.

**Treatment:**

John was treated with a multidisciplinary approach, including dietary recommendations, exercise counseling, patient education, and medications.

* Diet: Individualized dietary recommendations were provided to focus on whole foods, high-quality carbohydrates, and accommodating requirements posed by comorbid conditions.
* Exercise: John was advised to engage in at least 150 minutes of moderate-intensity aerobic exercise per week, with adjustments for hypoglycemia risk.
* Medications:
	+ Metformin 500 mg twice daily
	+ Aspirin 81 mg once daily for cardiovascular protection
	+ Atorvastatin 40 mg once daily for dyslipidemia
	+ Insulin glargine 10 units at bedtime for basal insulin coverage

**Patient Education:**

John received detailed education on the causes of diabetes, symptoms and signs of hypoglycemia and hyperglycemia, and diabetic complications. He was also educated on adjusting insulin doses based on blood glucose levels and carbohydrate intake.

**Discharge Instructions:**

John was discharged with the following instructions:

* Continue metformin 500 mg twice daily
* Continue aspirin 81 mg once daily
* Continue atorvastatin 40 mg once daily
* Continue insulin glargine 10 units at bedtime
* Monitor blood glucose levels regularly and adjust insulin doses as needed
* Perform regular foot and funduscopic examinations
* Attend regular follow-up appointments with the endocrinologist
* Continue to engage in regular physical activity
* Monitor for signs of hypoglycemia and hyperglycemia

**Follow-up Care:**

John was scheduled for a follow-up appointment with the endocrinologist in two weeks to monitor his blood glucose control and adjust his treatment plan as needed.

**Additional Recommendations:**

John was recommended to receive regular professional podiatric care due to his risk of sensory loss or circulatory impairment. He was also advised to get vaccinated against Streptococcus pneumoniae, influenza virus, hepatitis B, varicella, and SARS-CoV-2.

**Special Instructions:**

John was instructed to avoid fixed recommendations on percentages of calories from carbohydrate, protein, or fat due to his individualized dietary needs. He was also advised to adjust insulin or carbohydrate intake before exercise to avoid hypoglycemia.

**Summary:**

John Doe, a 43-year-old male, was diagnosed with type 2 diabetes and treated with a multidisciplinary approach, including dietary recommendations, exercise counseling, patient education, and medications. He was discharged with a treatment plan that included metformin, aspirin, atorvastatin, and insulin glargine, and was instructed to monitor his blood glucose levels regularly and adjust his treatment plan as needed. Regular follow-up appointments with the endocrinologist were scheduled to monitor his blood glucose control and adjust his treatment plan as needed.